Cardiology · 2020 · 25 citations · 23 references
MedicineCardiologyInternal MedicineCardiovascular PharmacotherapyInterventional CardiologySurvival AnalysisHeart FailureLeft Ventricular Function AssessmentCardiovascular Recovery AssessmentLeft Ventricular Ejection Fraction DeclineLeft Ventricular Functional Recovery PredictionVentricular Ejection Fraction Assessment
<b><i>Background:</i></b> A significant number of heart failure (HF) patients with reduced left ventricular ejection fraction (LVEF) experience ventricular function recovery during follow-up. We studied the variables associated with LVEF recovery in patients treated with sacubitril/valsartan (SV) in clinical practice. <b><i>Methods:</i></b> We analyzed data from a prospective and multicenter registry including 249 HF outpatients with reduced LVEF who started SV between October 2016 and March 2017. The patients were classified into 2 groups according to LVEF at the end of follow-up (&#x3e;35%: group R, or ≤35%: group NR). <b><i>Results:</i></b> After a mean follow-up of 7 ± 0.1 months, 62 patients (24.8%) had LVEF &#x3e;35%. They were older (71.3 ± 10.8 vs. 67.5 ± 12.1 years, <i>p</i> = 0.025), and suffered more often from hypertension (83.9 vs. 73.8%, <i>p</i> = 0.096) and higher blood pressure before and after SV (both, <i>p</i> &#x3c; 0.01). They took more often high doses of beta-blockers (30.6 vs. 27.8%, <i>p</i> = 0.002), with a smaller proportion undergoing cardiac resynchronization therapy (14.8 vs. 29.0%, <i>p</i> = 0.028) and fewer implanted cardioverter defibrillators (ICD; 32.8 vs. 67.9%, <i>p</i> &#x3c; 0.001), this being the only predictive variable of NR in the multivariate analysis (OR 0.26, 95% CI 0.13–0.47, <i>p</i> &#x3c; 0.0001). At the end of follow-up, the mean LVEF in group R was 41.9 ± 8.1% (vs. 26.3 ± 4.7% in group NR, <i>p</i> &#x3c; 0.001), with an improvement compared with the initial LVEF of 14.6 ± 10.8% (vs. 0.8 ± 4.5% in group NR, <i>p</i> &#x3c; 0.0001). Functional class improved in both groups, mainly in group R (<i>p</i> = 0.035), with fewer visits to the emergency department (11.5 vs. 21.6%, <i>p</i> = 0.07). <b><i>Conclusions:</i></b> In patients with LVEF ≤35% treated with SV, not carrying an ICD was independently associated with LVEF recovery, which was related to greater improvement in functional class.
23
John G.F. Cleland, Andrew J.S. Coats, Ewa A. Jankowska et al. · PubMed · 2021 · 19.5K citations
Roberto M. Lang, Luigi P. Badano, Victor Mor‐Avi et al. · Journal of the American Society of Echocardiography · 2015 · 18K citations · Full text
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
John J.V. McMurray, Milton Packer, Akshay S. Desai et al. · New England Journal of Medicine · 2014 · 6.8K citations · Full text
Medicine, Cardiology, Pharmacology +11